3Fidel PL Jr, Lynch ME, Sobel JD. Circulating CD4 and CD8 T cells have little impact on host defense against experimental vaginal candidiasis. Infect Immun, 1995,63 (7) :2403 - 2408.
4Cantoma M, Mook D, Balish E. Resistance of congenitally immunodeficient gnotobiotic mice to vaginal candidiasis. Infect Immun, 1990,58(11) :3813 -3815.
6Taylor BN, Saavedra M, Fidel PL Jr. Local Thl/Th2 cytokine production during experimental vaginal candidiasis: potential importance of transforming growth factor-beta. Med Mycol, 2000, 38 (6):419 -431.
7Saavedra M, Taylor B, Lukacs N, et al. Local production of chemokines during experimental vaginal candidiasis. Infect Immun, 1999,67(11):5820-5826.
8Wormley FL Jr, Chalban J, Fidel PL Jr. Cell adhesion molecule and lymphocyte activation marker expression during experimental vaginal candidiasis. Infect Immun, 2001,69(8):5072 - 5079.
9Polonelli L, De Bernardis F, Conti S, et al. Idiotypic intravaginal vaccination to protect against candidal vaginitis by secretory, yeast killer toxin-like anti-idiotypic antibodies. J Immunol, 1994, 152(6): 3175-3182.
10de Bernardis F, Santoni G, Boccanera M, et al. Local anticandidal immune responses in a rat model of vaginal infection by and protection against Candida albicans. Infect Immun, 2000, 68(6) :3297 -3304.
